Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 18 of 18 entries
View as:

The Efficacy of Watch and Wait Strategy or Surgery After Neoadjuvant Immunotherapy for Locally Advanced Colorectal Cancer With dMMR/MSI-H Guided by MRD Dynamic Monitoring: A Single-center, Open-label, Prospective, Phase II Clinical Trial.

Phase: N/A Priority: Normal
NCT ID: NCT06477991 Org: User:
Start: 10/30/23 End: 10/30/26 Due: 10/30/27

DCE-MRI Based on 4D Free Breathing for Predicting Preoperative Neoadjuvant Chemoradiotherapy for Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06755866 Org: User:
Start: 11/26/24 End: 07/31/26 Due: 07/31/27

Study on the Value of Three DWI Scanning Sequences in Staging of Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06735105 Org: User:
Start: 12/23/23 End: 12/31/24 Due: 12/31/25

Application of Rapid On-site Evaluation in Lymph Node Biopsy of Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06495736 Org: User:
Start: 02/01/24 End: 02/28/26 Due: 02/28/27

The Application Value of Spectral CT in the Accurate Staging of Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06977412 Org: User:
Start: 06/01/25 End: 05/31/26 Due: 05/31/27

Correlation Between Serum TK1 and Pathological Remission of Breast Cancer With Neoadjuvant Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06509555 Org: User:
Start: 03/01/24 End: 02/28/26 Due: 02/28/27

Feasibility Study of Deep Learning-based MDixon Quant for Quantitative Assessment of Chemotherapy-induced Fatty Liver

Phase: N/A Priority: Normal
NCT ID: NCT06735118 Org: User:
Start: 12/25/23 End: 12/30/24 Due: 12/30/25

Single-arm, Single-center, Exploratory Phase II Clinical Study of Envafolimab Combined With Chemoradiotherapy in the Treatment of Locally Advanced pMMR/MSS Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06239870 Org: User:
Start: 04/01/23 End: 09/30/25 Due: 09/30/26

Prediction of Non-sentinel Lymph Node Metastatic Status of Breast Cancer Based on Pathology-MRI Images

Phase: N/A Priority: Normal
NCT ID: NCT06510738 Org: User:
Start: 08/31/24 End: 12/31/25 Due: 12/31/26

Tumor-Targeted-NIR-II Fluorescent Molecular Probes for the Identification of Breast Cancer Tissue and SLN Metastatic Status

Phase: N/A Priority: Normal
NCT ID: NCT06713161 Org: User:
Start: 09/01/24 End: 12/25/25 Due: 12/25/26

Trop2-targeting NIR-II Molecular Probe for Breast Cancer Precise Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06713681 Org: User:
Start: 05/13/24 End: 12/31/25 Due: 12/31/26

Application of DCE-MRI Based on 4D FreeBreathing in Predicting the Efficacy of Immune and Targeted Therapy in Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06742021 Org: User:
Start: 11/11/24 End: 07/31/26 Due: 07/31/27

Trop2-targeting NIR-II Molecular Probe for Guided Identification of Non-Muscle-Invasive Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06972771 Org: User:
Start: 01/17/25 End: 11/30/25 Due: 11/30/26

EpCAM-Targeted Surface-Enhanced Raman Spectroscopy Nanotags for Rapid Evaluation of Surgical Margins and Sentinel Lymph Node Metastasis Status in Breast Cancers

Phase: N/A Priority: Normal
NCT ID: NCT07018505 Org: User:
Start: 06/15/25 End: 07/01/26 Due: 07/01/27

The Application Value of Spectral CT in the Accurate Staging of Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06977386 Org: User:
Start: 06/01/25 End: 05/31/26 Due: 05/31/27

Evaluation of Axillary Lymph Node Metastasis Status of Breast Cancer Based on Pathological Images and Virtual Staining

Phase: N/A Priority: Normal
NCT ID: NCT06486155 Org: User:
Start: 08/31/24 End: 12/31/25 Due: 12/31/26

The Application Value of Spectral CT in the Accurate Staging of Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06977399 Org: User:
Start: 06/01/25 End: 05/31/26 Due: 05/31/27

The Application Value of Spectral CT in the Accurate Staging of Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06977373 Org: User:
Start: 06/01/25 End: 05/31/26 Due: 05/31/27